Peak ID | Rt, min | Found monoisotopic mass | MW, amu = Da | MF | Chemical name |
---|---|---|---|---|---|
2 | 0.68 | 272.9545 [M−H]− | 274.0590 | C13H10N2O5 | (E)-3-oxo-3-((1-(4-oxo-4H-Benzo[e][1,3]oxazin-2-yl)ethylidene)amino)propanoic acid, 1 |
2 |  | 387.0887 [M−H]− | 388.1522 | C21H24O7 | Xanthomonasin-A, 2 |
3 | 0.74 | 438.1913 [M−H]− | 439.1267 | C23H21NO8 | Mitorubrinolamine acetate, 3 |
 |  | 440.2273 [M+H]+ |  |  |  |
4 | 0.98 | 440.2050 [M+H]+ | Â | Â | Â |
 |  | 462.1462 [M+Na]+ |  |  |  |
 |  | 438.2209 [M−H]− |  |  |  |
4 |  | 357.1845 [M+H]+ | 356.1624 | C21H24O5 | Dihydrorubropunctatin, 4 or Monasfluore-A, 5 |
4 |  | 190.9803 [M−H]− | 192.0899 | C10H12N2O2 | Dihydrochrysogine, 6 |
4 |  | 412.1799 [M−H]− | 413.1838 | C23H27NO6 | Dehydroglycylrubropunctatin, 7 |
4 |  | 510.2267 [M−H]− | 511.2206 | C28H33NO8 | N-Glutarylmonascorubramine, 8 |
6 | 1.17 | 488.1899 [M+H]+ | 487.3086 | C32H41NO3 | Talaroconvolutin-A, 9 |
 |  | 486.2599 [M−H]− |  |  |  |
6 |  | 119.9371 [M+H]+ | 119.0219 | C3H5NO4, | β-Nitropropanoic acid, 10 |
7 | 1.28 | 488.2377 [M+H]+ | 487.3086 | C32H41NO3 | Talaroconvolutin-A, 9 |
 |  | 486.2180 [M−H]− |  |  |  |
7 |  | 539.3469 [M+H]+ | 538.0900 | C30H18O10 | Skyrin, 11 |
8 | 1.47 | 424.3120 [M−H]− | 425.2202 | C25H31NO5 | PP-R; 7-(2-Hydroxyethyl)monascorubramine, 12 |
 |  | 426.2246 [M+H]+ |  |  |  |
8 |  | 428.3271 [M−H]− | 429.2515 | C25H35NO5 | Tetrahydro-PP-R, 13 |
 |  | 430.1977 [M+H]+ |  |  |  |
9 | 2.75 | 227.0675 [M+H]+ | 226.1205 | C12H18O4 | 2,4-Dihydroxypentyl)-2-methylbenzene-1,3diol, 14 |
11 | 6.13 | 470.4424 [M−H]− | 471.2773 | C31H37NO3 | Deoxytalaroconvolutin-A, 15 |
12 | 6.80 | 352.1925 [M−H]− | 353.1627 | C21H23NO4 | Rubropunctamine, 16 |
14 | 7.84 | 697.4280 [M+H]+ | 696.2692 | C40H44N2O5S2 | Hydrooxy-present pigment, 17 |
 |  | 695.4290 [M−H]− |  |  |  |
14 |  | 349.3371 [M+H]+ | 348.1209 | C18H20O7 | Glauconic acid, 18 |
15 | 8.32 | 502.1199 [M−H]− | 503.3036 | C32H41NO4 | Dehydrotalaroconvolutin-B |
 |  |  |  |  | Dehydro ZG-1494a, 19 |
16 | 9.38 | 390.1997 [M+H]+ | 389.2202 | C22H31NO5 | Dehydro-Purpuride, 20 |
16 |  | 430.2012 [M+H]+ | 429.2515 | C25H35NO5 | Tetrahydro-PP-R, 21 |
16 |  | 452.2859 [M−H]− | 453.1788 | C25H27NO7 | Dehydro-N-threoninerubropunctamine, 22 |
17 | 10.24 | 221.2123 [M−H]− | 222.0892 | C12H14O4 | 1-(3,5-Dihydroxy-4-methylphenyl)pentane-2,4-dione, 23 |
17 |  | 401.1828 [M−H]− | 402.1315 | C21H22O8 | Pinophilin-B, 24 |
17 |  | 472.3087 [M−H]− | 473.2930 | C31H39NO3 | Demethyltalaroconvolutin-A, 25 |
17 |  | 494.3125 [M−H]− | 495.1893 | C27H29NO8 | Dehydroazaphilone pigment, 26 |
17 |  | 562.2547 [M−H]− | 563.3611 | C35H49NO5 | Talaroconvolutin-D, 27 |
18 | 11.26 | 476.2532 [M+H]+ | 475.3086 | C31H41NO3 | Demethyl-dihydrotalaroconvolutin-A, 28 |
18 |  | 474.2838 [M−H]− |  |  |  |
18 |  | 498.2573 [M+H]+ | 497.2050 | C27H31NO8 | Azaphilone pigment, 29 |
 |  | 496.3168 [M−H]− |  |  |  |
19 | 11.55 | 539.2065 [M−H]− | 540.2108 | C28H32N2O9 | N-glutamylmonascorubraminic acid, 30 |
19 |  | 392.1892 [M+H]+ | 391.2359 | C22H33NO5 | Purpuride, 31 |
 |  | 414.2019 [M+Na]+ |  |  |  |
20 | 11.66 | 436.2874− [M+HCO2]− |  |  |  |
20 |  | 233.1178 [M+H]+ | 232.0199 | C14H16O3 | Sorbicillin, 32 |
19 |  | 293.1682 [M−H]− | 294.1256 | C19H18O3 | 3-Hydroxy-1,8,8,9-tetramethyl-8,9-dihydro-4H-phenaleno[1,2-b]furan-4-one (Atrovenetin derivative, 33) |
20 |  | 293.1252 [M−H]− | 294.0852 | C13H14N2O6 | 2-(2-(2-Carboxyacetamido)propanamido)-benzoic acid,(Atrovenetin metabolite, 34) |
20 |  | 385.1713 [M−H]− | 386.2093 | C23H30O5 | Ankaflavin, 35 |
21 | 11.78 | 274.2042 [M+H]+ | 273.0750 | C13H11N3O4 | The oxidized form of (E)-3-oxo-3-((1-(4-oxo-1,4-dihydroquinazolin-2-yl)ethylidene)-amino)-propanoic acid (Atrovenetin metabolite, 36) |
 |  | 296.2686 [M+Na]+ |  |  |  |
22 | 11.90 | 412.2079 [M+H]+ | 411.1682 | C23H25NO6 | PP-V pigment, 37 or purpactin C |
22 |  | 318.3012 [M+H]+ | 317.0648 | C14H11N3O6 | (E)-2-((1-(4-oxo-1,4-Dihydroquinazolin-2-yl)ethylidene)carbamoyl)malonic acid, 38 |
 |  | 340.3239 [M+Na]+ |  |  |  |
22 |  | 230.1811 [M+H]+ | 229.0851 | C12H11N3O2 | (E)-N-(1-(4-oxo-1,4-Dihydroquinazolin-2-yl)ethylidene)acetamide, 39 |
23 | 12.33 | 475.4114 [M−H]− | 476.2563 | C30H36O5 | Sophoraisoflavanone-C, 40 |
24 | 12.87 | 415.1910 [M+H]+ | 414.1679 | C23H26O7 | Dihydro PP-O |
 |  | 437.1733 [M+Na]+ |  |  | Or Purpactin-A & B, 41 |
 |  | 453.1935 [M+K]+ |  |  |  |
24 |  | 617.3195 [M+H]+ | 616.4128 | C40H54O5 | Dihydro-4-ketonostoxanthin, 42 |
25 | 13.33 | 395.2523 [M−H]− | 396.0845 | C21H16O8 | Mitorubrinal, 43 |
25 |  | 327.1714 [M−H]− | 328.0947 | C18H16O6 | (R)-3,7-Dihydroxy-1,8,8,9-tetramethyl-8,9-dihydro-4H,6H-benzo[de]furo[2,3g]isochromene-4,6-dione, 44 |
26 | 16.62 | 399.2009 [M+H]+ | 398.1002 | C21H18O8 | Mitorubrinol, 45 |
26 |  | 383.1822 [M+H]+ | 382.1780 | C23H26O5 | PP-Y; Monascorubrin, 46 |
26 |  | 301.0924 [M+H]+ | 300.0270 | C15H8O7 | Emodic acid, 47 |
27 | 17.91 | 506.3542 [M+H]+ | 505.3192 | C32H43NO4 | Talaroconvolutin-B, 48 |
 |  | 528.3842 [M+Na]+ |  |  | (ZG-1494a) |
 |  |  |  |  | Two stereoisomers at C-5 or 26 |
28 | 20.36 | 339.2800 [M−H]− | 340.1311 | C20H20O5 | Dehydroatrovenetin, 49 |
29 | 20.84 | 359.2497 [M+H]+ | 358.1780 | C21H26O5 | Monascin, 50 |
29 |  | 239.1775 [M+H]+ | 238.1722 | C18H22 | 2,3,9,10-Tetramethyl-1,2,3,4-tetrahydroanthracene, 51 |
30 | 22.79 | 589.1694 [M−H]− | 590.1061 | C30H22O13 | Deoxyxanthoepoein, 52 |
30 |  | 385.0434 [M−H]− | 386.1366 | C21H22O7 | Azaphilone, 53 |
32 | 23.40 | 613.1418 [M−H]− | 614.1636 | C30H30O14 | Octahydroxanthoepoein, 54 |
34 | 23.64 | 403.3223 [M−H]− | 404.2199 | C23H32O6 | Hydrolytic product of Ankaflavin, 55 |
39 | 25.19 | 283.2244 [M−H]− | 284.0685 | C16H12O5 | Erythroglaucin, 56 |
40 | 25.28 | 283.1718 [M−H]− | 284.0685 | C16H12O5 | Physcion, 57 |
41 | 25.35 | 384.1975 [M−H]− | 385.2253 | C23H31NO4 | Tetrahydromonascorubramine, 58 |
42 | 25.41 | 391.2597 [M+H]+ | 390.1234 | C21H23ClO5 | Sclerotiorin, 59 (Orange azaphilone pigment) |
 |  | 413.2316 [M+Na]+ |  |  |  |
52 | 26.65 | 357.0226 [M−H]− | 358.1053 | C19H18O7 | Norherqueinone, 60 |